404
GI Stool Testing Market Report
Global GI Stool Testing Market, Dynamics, Market Analysis
The report on the Global GI Stool Testing Market is segmented, By Product (Instruments, Reagents), By Test Type (Occult Blood Test, Ova and Parasites Test, Bacteria Test, Fecal Biomarkers Test, Other Test Types), By End Use (Hospitals, Diagnostic Centers And Laboratories, Academic Institutions, Research Centers & Organizations, Home) and Region - COVID-19 Impact Analysis and Forecast to 2026....
The GI stool testing market is expected to witness an impressive growth of 7.4% CAGR in the foreseeable future.
Abbott Laboratories (The US), Beckman Coulter Inc. (The US), bioMerieux SA (France), Cardinal Health (The US), Cenogenics Corporation (The US), CTK Biotech Inc. (The US), Genova Diagnostics (The US), Epitope Diagnostics Inc. (The US), ScheBo Biotech AG (Germany), and MERIDIAN BIOSCIENCE INC. (The US) are among the key players in the GI stool testing market.
The growing healthcare awareness and rising healthcare expenditure by the government & private sector, The increasing prevalence of GI health disorders owing to rising consumption of fast food, stress & hectic lifestyle, as well as the growing geriatric population who are highly susceptible to GI infections are the factors driving the growth of GI stool testing market.
North America market witnessed the highest market share in 2020 and is projected to grow at a robust CAGR during the review period.
The reagents segment accounted for the highest market share in 2020 and is likely to register a steady CAGR during the review period.
GI stool testing companies, Hospitals, Diagnostic Centers And Laboratories, Academic Institutions, Research Centers & Organizations are the target audience in the GI stool testing market.